✦ LIBER ✦

Lenalidomide and dexamethasone for the treatment of refractory/relapsed multiple myeloma: dosing of lenalidomide according to renal function and effect on renal impairment

✍ Scribed by Meletios A. Dimopoulos; Dimitrios Christoulas; Maria Roussou; Efstathios Kastritis; Magdalini Migkou; Maria Gavriatopoulou; Charis Matsouka; Despoina Mparmparoussi; Erasmia Psimenou; Irini Grapsa; Eleni Efstathiou; Evangelos Terpos

Book ID: 114794757
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 72 KB
Volume: 85
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2010.01432.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The efficacy and safety of lenalidomide

The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function

✍ Meletios Dimopoulos; Adrian Alegre; Edward A. Stadtmauer; Hartmut Goldschmidt; J 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 1 views

Lenalidomide is effective for extramedul

Lenalidomide is effective for extramedullary disease in relapsed or refractory multiple myeloma

✍ José M. Calvo-Villas; Adrián Alegre; Carmen Calle; Miguel T. Hernández; Ricarda 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

Successful Treatment of Patients With Mu

Successful Treatment of Patients With Multiple Myeloma and Impaired Renal Function With Lenalidomide: Results of 4 German Centers

✍ Katharina Oehrlein; Christian Langer; Isrid Sturm; Wolfram Pönisch; Corinna Hahn 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 297 KB

Prognostic Risk Factor Evaluation in Pat

Prognostic Risk Factor Evaluation in Patients With Relapsed or Refractory Multiple Myeloma Receiving Lenalidomide Treatment: Analysis of Renal Function by eGFR and of Additional Comorbidities by Comorbidity Appraisal

✍ Martina Kleber; Gabriele Ihorst; Josefina Udi; Bernd Koch; Ralph Wäsch; Monika E 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 528 KB

Treatment of patients with relapsed/refr

Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies

✍ Dimopoulos, M A; Kastritis, E; Christoulas, D; Migkou, M; Gavriatopoulou, M; Gko 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 473 KB

Effect of Body Composition and Renal Fun

Effect of Body Composition and Renal Function on the Pharmacokinetics of High-Dose Melphalan for Multiple Myeloma

✍ D.T. Vogl; R. Mick; E. Stoopler; L.E. Davis; T.M. Paul; G. Salazar; M. Raguza-Lo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB